Impact of COVID-19 on the management of patients with metastatic melanoma

Source: Medical Xpress, January 2023

A new research paper titled “Impact of COVID-19 on the management of patients with metastatic melanoma" has been published in Oncotarget.

The COVID-19 pandemic created new uncertainties in the management of metastatic melanoma patients. In particular, the impact of immunotherapy, targeted therapy or chemotherapy on the risk of SARS-CoV-2 infection and severity was debated.

In this study, researchers Michèle Welti, Phil F. Cheng, Joanna Mangana, Mitchell P. Levesque, Reinhard Dummer, and Laurence Imhof from University Hospital Zurich, University of Zurich and ETH Zurich analyzed all patients with metastatic melanoma receiving therapy at the University Hospital Zürich who developed COVID-19 between February 2020 and February 2022.
READ THE ORIGINAL FULL ARTICLE